What is the best treatment approach for patients with chronic low iron (iron deficiency)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Approach for Chronic Iron Deficiency

Ferrous sulfate 324 mg (65 mg elemental iron) once daily is the preferred first-line treatment for chronic iron deficiency, with alternative-day dosing as an option for improved tolerability. 1

Initial Treatment Algorithm

First-Line Therapy: Oral Iron

  • Formulation: Ferrous sulfate is preferred as the least expensive iron formulation 1

    • Standard dose: 324 mg (65 mg elemental iron) 2
    • No single formulation has advantages over others 1
  • Dosing frequency:

    • Once daily dosing (maximum) 1
    • Consider every-other-day dosing for better tolerance with similar absorption rates 1
  • Administration tips:

    • Take on an empty stomach for optimal absorption
    • Add vitamin C (such as orange juice) to improve absorption 1
    • If GI side effects occur, try:
      • Alternate-day dosing
      • Different iron formulation (ferrous gluconate or ferrous fumarate)
      • Taking with small amounts of food if necessary 3

Second-Line Therapy: Intravenous Iron

Switch to IV iron when:

  1. Patient does not tolerate oral iron 1
  2. Ferritin levels don't improve with oral iron trial 1
  3. Patient has conditions where oral iron absorption is impaired:
    • Inflammatory bowel disease with active inflammation [1, @9@]
    • Post-bariatric surgery 1, 4
    • Celiac disease not responding to gluten-free diet [1, @13@]
    • Ongoing blood loss 5
  • Preferred IV formulations: Those requiring only 1-2 infusions to replace iron deficit 1
  • Safety note: True anaphylaxis is rare; most reactions are complement activation-related pseudo-allergy 1

Monitoring Response

  1. Initial follow-up: Check hemoglobin after 2-4 weeks

    • Critical decision point: Increase in hemoglobin of ≥10 g/L after 2 weeks strongly predicts successful treatment 3
  2. Ongoing monitoring:

    • Continue monitoring every 4 weeks until hemoglobin normalizes 3
    • Long-term follow-up: Check hemoglobin and iron studies (ferritin, TSAT) every 3 months during maintenance phase 3

Special Populations

Inflammatory Bowel Disease

  • Determine if iron deficiency is due to inadequate intake/absorption or blood loss 1
  • Treat active inflammation to enhance iron absorption 1
  • Use IV iron therapy in those with active inflammation and compromised absorption 1

Portal Hypertensive Gastropathy

  • Start with oral iron supplements 1
  • Switch to IV iron if ongoing bleeding with poor response to oral therapy 1
  • Consider nonselective β-blockers to treat portal hypertension 1

Celiac Disease

  • Ensure adherence to gluten-free diet to improve iron absorption 1
  • Consider oral iron based on severity and tolerance 1
  • Use IV iron if stores don't improve 1

Post-Bariatric Surgery

  • IV iron therapy is recommended, particularly after procedures that disrupt duodenal iron absorption 1

Common Pitfalls to Avoid

  1. Overtreatment: Excessive iron supplementation can cause iron overload 4
  2. Premature discontinuation: Continue treatment until both clinical symptoms and laboratory parameters normalize 3
  3. Inadequate monitoring: Follow hemoglobin and iron studies regularly 3
  4. Ignoring non-response: Evaluate for ongoing blood loss or absorption issues if no improvement 3
  5. Mistaking infusion reactions for anaphylaxis: Most IV iron reactions are pseudo-allergic 1
  6. Using inappropriate ferritin cutoffs in patients with inflammation 3

Iron deficiency is the most common nutritional deficiency worldwide, affecting approximately 2 billion people 5. Proper diagnosis and treatment are essential to prevent complications including fatigue, reduced exercise tolerance, and impaired cognitive function.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Macrocytosis and Anemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.